# Multivariate Cox Model: Explanation and Implementation Plan

## What Your PI is Suggesting

Your PI wants you to run a **multivariate Cox proportional hazards model** instead of (or in addition to) the current univariate model that only includes ctDNA.

### Current Analysis (Univariate)
- **Model**: `Surv(os_time, os_event) ~ log(ctDNA + 1)`
- **Question**: Is ctDNA associated with survival?
- **Limitation**: Doesn't account for other factors that might explain the association

### Proposed Analysis (Multivariate)
- **Model**: `Surv(os_time, os_event) ~ log(ctDNA + 1) + age + sex + stage + ...`
- **Question**: Is ctDNA **independently** associated with survival after adjusting for other prognostic factors?
- **Benefit**: Tests whether ctDNA adds prognostic value beyond known clinical variables

## Why This Matters

1. **Confounding**: ctDNA might be correlated with other prognostic factors (e.g., higher ctDNA in patients with worse performance status, more advanced disease, etc.)
2. **Clinical Relevance**: If ctDNA remains significant after adjusting for other factors, it suggests it's a truly independent prognostic biomarker
3. **Publication Standard**: Most journals expect multivariate models to demonstrate independent prognostic value

## What the Referenced Paper Likely Did

The paper you referenced (S2588931125002469) likely:
- Started with a univariate model showing ctDNA is prognostic
- Then built a multivariate model including:
  - ctDNA level
  - Age
  - Performance status (ECOG)
  - Disease stage/extent
  - Prior treatment history
  - Other known prognostic factors
- Showed that ctDNA remained significantly associated with survival after adjustment

## Clinical Variables to Consider

Based on your dataset structure, here are variables that appear to be available:

### Demographics
- **Race** (`race`)
- **Ethnicity** (`ethnicity`)
- **Age** (check if available)
- **Sex/Gender** (check if available)

### Disease Characteristics
- **Cancer Stage** (`cancer_stage_natera`)
- **T Stage** (`pathology_t_stage_2` or other pathology_t_stage columns)
- **N Stage** (`pathology_n_stage_2` or other pathology_n_stage columns)
- **M Stage** (`pathology_m_stage_2` or other pathology_m_stage columns)
- **Histology subtype** (check if available)
- **Primary tumor location** (check if available)

### Treatment History
- **Prior systemic therapy** (already captured in your universe definition)
- **Prior radiation** (already captured in your universe definition)
- **Neoadjuvant therapy** (`neoadjuvant_systemic_therapy_yes_no` - if available)
- **Time from prior therapy** (already calculated as `years_from_therapy`)

### Clinical Status
- **Performance status** (ECOG - check if available)
- **Time from diagnosis to ctDNA measurement** (can be calculated)
- **Dataset** (upper vs lower tract - already available)

## Implementation Steps

1. **Identify Available Variables**: Check which clinical variables are available in your dataset for the 126 patients in the analysis
2. **Assess Completeness**: Determine which variables have sufficient data (>80% complete is ideal)
3. **Build Multivariate Model**: Include ctDNA + clinically relevant variables
4. **Model Selection**: Consider stepwise selection or include all variables with <20% missing
5. **Compare Models**: Show univariate vs multivariate results

## Example Model Structure

```r
# Univariate (current)
cox_univariate <- coxph(Surv(os_time, os_event) ~ log(ctdna_diagnosis_value + 1), 
                         data = outcomes)

# Multivariate (proposed)
cox_multivariate <- coxph(Surv(os_time, os_event) ~ 
                           log(ctdna_diagnosis_value + 1) +  # ctDNA (primary variable)
                           age +                              # Age
                           sex +                              # Sex
                           stage_4 +                          # Stage IV (yes/no)
                           prior_therapy,                      # Prior therapy (yes/no)
                         data = outcomes)
```

## Interpretation

- **If ctDNA remains significant (p < 0.05) in multivariate model**: ctDNA is independently prognostic
- **If ctDNA becomes non-significant**: The association might be explained by other factors
- **Compare HRs**: The HR for ctDNA in multivariate model shows the independent effect

## Next Steps

1. Check what clinical variables are available in your dataset
2. Assess data completeness for each variable
3. Build the multivariate model
4. Present both univariate and multivariate results side-by-side

